INTRODUCTİON
Motor, sensory and autonomic dysfunctions are consequences of spinal cord injury (SCI) occuring on the cervical spine causing problems in cervical, thoracic, lumbar, and sacral levels under injury (1) . SCI are accompanied by apoptosis of neurons and the initiation of glial cells, that result in neurological dysfunction. Lesion on spinal cord triggers infiltration of inflammatory cells and irreversible loss of neurons (2, 3) . Neurologic damage occuring after acute spinal cord injury involves necrosis after primary mechanic injury and secondary injury then, apoptosis takes place (4) So, previous studies reveal strong evidence demonstrating the presence of apoptosis after SCI.
Pathogenesis of spinal cord neuronal lesion after injury is also related with oxygenderived free radical formation leading to edema and inflammatory response. After spinal cord lesion disabilities and deficits such as; loss of motor, sensory and autonomic sensory system capabililties, muscle spasms, chronic pain, urinary tract diseases may appear (5) . A study on imatinib was demonstrated that functional outcomes like locomotor capacity and bladder function and also histological parameters (tissue sparing, axonal sparing, astrogliosis, inflammation and BSCB permeability) were improved following spinal cord weight-drop lesion (6) . ability to inhibit xanthine oxidase in previous studies that in the brain, xanthine oxidase is concentrated within endothelial cells, subject the blood-brain barier to free radical attack (18) .
Bcl-2 family proteins monitor apoptosis and regulate this complex molecular network.
Various cellular events such as DNA damage, energy stress, loss of growth factor signaling and hypoxia can initiate apoptosis by activation of these proteins. The Bcl-2 family proteins takes prominent role such as; regulation of mitochondrial or intrinsic apoptotic response (19) .
Apoptosis causes the death of neuronal cells, particularly neurons and oligodendrocytes in the spinal cord after lesion, later corrupts axonmyelin anatomical unit and gives rise to an interruption in impulse transmission leading to neuronal loss (20, 21) .
Glial fibrillary acidic protein (GFAP) acts in astrocyte-neuronal interconnection and synaptic transmission (22) . As an intermediate filament protein GFAP is found in the skeleton of astroglia. Previous studies indicated that increased GFAP immunoreactivity is a sensible indicator of neuronal damage in tissue and an increase in GFAP is also an indicator of reactive astrocytosis. Damage caused by a trauma or disease in cerebral tissue or spinal cord cells is known to initiate an acceleration in blood GFAP level (23) (24) (25) .
In this experimental study, the role of allopurinol in rats with spinal cord injury and the immunohistochemical expression of GFAP and Bcl-2 proteins were investigated.
MATERIALS AND METHODS

Animals
Every single surgical methodology and the consequent care and healing of the animals utilized as a part of this investigation were in strict understanding with the National Institutes of Health (NIH Publications No. 8023, revised 1978) rules for animal care. All experimental protocols were approved by the Dicle University Animal Care and Use Committee. Male Sprague Dawley rats (n:30) weighing 250-290 g were kept under the conditions of 22±1°C and 12/12 hr light/dark cycles with standard pellet and water ad libitum. All rats at the end of experiment were healthy and no difference in food/water consumption and body weight gain between experimental and control rats were observed. Rats were separated into 3 groups as; control group, trauma group and trauma + allopurinol group. Isotonic saline solution (an equal volume of Allopurinol) was administered i.p. for 7 days in the control and trauma groups.
Fifteen min following trauma, the allopurinol solution was injected intraperitoneally for 7 days at a concentration of 50 mg/kg of body weight (Urikoliz 300 mg, Ilsan, Turkey, 50 mg / kg). Spinal cord tissue taken from L1-L2 spinal cord segments was extracted, fixed in a 10%
formalin solution, and embedded in paraffin blocks for histopathologic examination in all groups. Sections (5µm thick) were obtained from paraffin blocks and stained with Hematoxylin-Eosin for light microscopy examination.
Surgical procedure
Experimental animals were anesthetized intraperitoneally with ketamine and chlorpromazine 75 mg/kg and 1 mg/kg, separately (26) . Each rat was then positioned on a heating pad in a prone position and a rectal test was embedded. Under aseptic conditions, following T5-12 midline skin incision and paravertebral muscle dissection, spinous procedures and laminar arcs of T5-12 were evacuated. The particular relative angulation of the spinous procedures of the T9, T10, and T11 vertebrae was utilized as an imperative intraoperative landmark: T9 points caudally, T10 points directly dorsal, and T11 points rostrally. This delivers a solid ''triangle'' introduction that can be promptly checked whether the animal is positioned flat on the operating table. After the T11 and T12 vertebrae had been distinguished, a laminectomy was performed at T11 and T12 with Friedman-Pearson rongeurs. The clasp was then held open with a clasp utensil, with the lower cutting edge of the clasp passed extradurally completely around the spinal cord and nerve roots at the intersection between the T11 and T12 vertebrae, comparing to the L1-L2 spinal cord segmental level. The clasp was then quickly discharged from the tool to deliver a bilateral impact force and sustained dorsal-ventral compression. The compression of the spinal cord was kept up for 60 sec before expulsion of the clasp. The muscles were then sutured utilizing 3-0 polyglactin sutures, and the skin was shut with Michel clips (27) . Following surgical system, the rats were put in warming chamber and their body temperatures were kept up at roughly 37°C until the point when they were totally conscious. An hour after the spinal cord injury, only saline was injected intraperitoneally to the trauma group.
Histological preparation and analysis
At the end of the experiment, all animals were anesthetized via the intraperitoneal administration of ketamine HCL (0.15 ml/100 g body weight). The spinal cords were dissected. The sections were subjected to Hematoxylen-Eosin staining for observation under a light microscope.
Hematoxylin -EosinStaining Procedure
1. Deparaffinize sections, 2 changes of xylene, 10 minutes each.
2. Re-hydrate in 2 changes of absolute alcohol, 5 minutes each.
3. 95% alcohol for 2 minutes and 70% alcohol for 2 miuntes. 
Immunohistochemical staining
An antigen-retrieval process was performed in citrate buffer solution (pH 6.0) two times: first for 8 min, and afterward for 5 min in a microwave oven at 700 W. They were permitted to cool to room temperature for 20 min and washed in distilled water twice for 6 min. Endogenous peroxidase action was hindered in 0.1% hydrogen peroxide for 15 min. An ultra V block (Histostain-Plus Kit, Invitrogen, Carlsbad, CA) was connected for 10 min before the use of the primary antibodies (Bcl-2 antibody, mouse monoclonal, 1/100, Santa Cruz Biotechnology, US) and GFAP antibody (mouse monoclonal, 1/100, Abcam, UK) overnight. The secondary antibody (Histostain-Plus Kit, Invitrogen, Carlsbad, CA) was connected for 15 min. At that point, the slides were exposed to streptavidin-peroxidase for 15 min. Diaminobenzidine (DAB, Invitrogen, Carlsbad, CA) was utilized as a chromogen.
Control slides were set up as specified above yet overlooking the primary antibodies. In the wake of counterstaining with Hematoxylene, washing in tap water for 5 min, and in refined water for 2 × 5 min, the slides were mounted.
Measurement of myeloperoxidase (MPO) activity
The MPO activity levels were measured using the method described by Hillegass et al. (28) . Spinal cord tissue specimens were homogenized in 50 mM potassium phosphate buffer with a pH of 6.0 and centrifuged at 41,400 g for 10 min. The pellets were then suspended in 50 mM PB containing 0.5% hexadecyl trimethyl-ammonium bromide (HETAB). After three freezes and defrost cycles, with sonication between cycles, the samples were centrifuged at 41,400 g for 10 min. Aliquots (0.3 ml) were added to 2.3 ml of the response mixture containing 50 mM PB, o-dianisidine, and 20 mM H2O2 solution. One unit of enzyme action was characterized as the measure of MPO presence that caused an adjustment in absorbance, estimated at 460 nm for 3 min. MPO action was expressed as U/g tissue.
Malondialdehyde (MDA) and glutathione (GSH) assays
Spinal cord tissue samples were homogenized with super cold 150 mMKCl for the assurance of MDA and GSH levels. The MDA levels were tested for the products of lipid peroxidation and the outcomes are expressed as nmol MDA/g tissue (29) . GSH was resolved by a spectrophotometric technique in light of the utilization of Ellman's reagent and the outcomes are expressed as μmol GSH/g tissue (30) .
Statistical analysis
All information is expressed as means ± standard deviation. Groups of information were contrasted and an analysis of variance (ANOVA) trailed by Tukey's various correlation samples. Estimations of p value (p<0.05, versus control; p<0.001, versus control; p<0.01, trauma+allopurinol versus trauma; p<0.001, trauma+allopurinol versus trauma) were considered as significant.
RESULTS
Control, trauma and trauma + allopurinol groups were analyzed for biochemical data.
MPO action, which is acknowledged as an indicator of inflammatory cells, was fundamentally higher in the spinal cord tissues of disturbed rats than those of the control group (p<0.001).
Allopurinol treatment reduced spinal cord tissue MPO levels (p<0.01) when compared to the trauma group. The injury caused a significant increment in the MDA levels (p<0.001) with a reduction in GSH levels (p<0.001). Allopurinol caused a decrease in MDA levels and reestablished the GSH content at day 7. 
Histopathologic findings
In the cross-section of the control group; spinal cord, ependymal canal, which was paved with cylindrical epithelium, multipolar and bipolar neurons were diffusely distributed in substantia grisea. In the substantia alba layer, regular and nerve extension of the glial cells were observed (Figure 2a ). In the trauma group, hyperplasia of epithelial cells with dilatation of the ependymal canal, and degenerative changes in multipolar and bipolar neurons together with apoptotic changes in some glial cells were observed. In the substantia grisea and alba layer, congestion in the vessels and degeneration in the endothelial cells and ruptures in the nerve extensions were observed (Figure 2b ). In the group treated with allopurinol after trauma, mild degenerative changes were observed in multipolar and bipolar neurons compared to the trauma group, while the structure of the blood vessels in the endothelial cells was preserved (Figure 2c ).
Immunohistochemical findings
In the control group, Bcl-2 was weakly expressed in the cytoplasm of neurons of GFAP is a brain-specific protein that acts as the major integral component of the cell skeleton of astrocytes. After brain injury, GFAP releases the brain cells into the interstitial fluid in the environment and causes deterioration in the blood-brain barrier (40) . In many pathological conditions of the Central Nervous System and astrocytes, GFAP expression is increased. Studies on experimental animals revealed GFAP positive expression in astroglial cells following traumatic brain injury (41, 25) . Allopurinol is a specific inhibitor of xanthine oxidase, and it blocks the synthesis of xanthine from hypoxanthine and inhibits the formation of free radical superoxide (42) . In the trauma group of our study, GFAP expression in glial cells was evaluated as positive with degenerative neuron and a decrease in astrocytic ankles around dilated blood vessels (Figure 4b ). In the allopurinol treated group, glial feet around the blood vessel were regular and it was showed that GFAP protein expression increased in multipolar and bipolar neuron extensions (Figure 4c ).
Studies have shown that allopurinol leads to a decrease in the levels of free radical production and reduces tissue damage associated with I / R injury (42, 43) . It is both a strong xanthine oxidase inhibitor and an agent that decreases ischemia related mitochondrial dysfunction (43, 44) . As a result of a study by Moorhouse et al., high doses have been suggested for the neuroprotective effects of allopurinol. It has also been shown that high levels of allopurinol and its metabolite oxypurinol in the blood can act as a scavenger and move hydroxyl radical and transition metal chelating agents (35) . On the contrary, another study indicated that the high dose allopurinol had an intraperitoneal protective effect but showed no therapeutic effect in transient focal cerebral ischemia in the three-vessel occlusion model in rats (44) .
Despite the results, there are a few limitations. Allopurinol may be applied for a longer period of time however, we applied for 7 days and examined its short-term effect. We also preferred a lower dose, unlike high doses, not to enable a toxic effect. Known side effects of allopurinol are dermatologic (pruritic, erythematous, or macropapular eruptions), hematologic (leukopenia and/or eosinophilia, white blood count abnormalities), and hepatologic (increase in liver enzymes) (45) so, it was investigated whether allopurinol has an osteoblastic effect at lower dosages, since short-term administration at minimal concentrations would be more appropriate.
CONCLUSIONS
We think that GFAP expression in glial processes deteriorated in the multipolar, bipolar neuron extensions and blood vessel environment after spinal cord injury and in inflammatory response after trauma and tissue damage. We are in the opinion that allopurinol has an antioxidative effect and it may induce GFAP protein activity in traumatic spinal cord injury which may affect the repairment process in nerve connections and ependymal cells after the trauma. As a conclusion, allopurinol can partially prevent degenerative changes in nerve cells and glial cells and decrease apoptotic changes due to Bcl-2 expression. 
